Genomic landscape of non-small cell lung cancer in smokers and never-smokers.
Govindan, Ramaswamy; Ding, Li; Griffith, Malachi; Subramanian, Janakiraman; Dees, Nathan D; Kanchi, Krishna L; Maher, Christopher A; Fulton, Robert; Fulton, Lucinda; Wallis, John; Chen, Ken; Walker, Jason; McDonald, Sandra; Bose, Ron; Ornitz, David; Xiong, Donghai; You, Ming; Dooling, David J; Watson, Mark; Mardis, Elaine R; Wilson, Richard K.
; 150(6): 1121-34, 2012 Sep 14.
Artigo em Inglês | MEDLINE | ID: mdl-22980976
Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution.
Genome-wide CRISPR screen in a mouse model of tumor growth and metastasis.
Lung Cancer: A Wily Genetic Opponent.
The biology and management of non-small cell lung cancer.
Metabolic Heterogeneity in Human Lung Tumors.
Catastrophic nuclear envelope collapse in cancer cell micronuclei.
Recognition of histone acetylation by the GAS41 YEATS domain promotes H2A.Z deposition in non-small cell lung cancer.
Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent.
Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing.
Epigenetic Therapy Ties MYC Depletion to Reversing Immune Evasion and Treating Lung Cancer.